FDA Withdraws Approval of 37 Abbreviated New Drug Applications
The FDA withdrew approval of 37 abbreviated new drug applications at the request of applicants who stopped marketing the products.
The FDA withdrew approval of 37 abbreviated new drug applications at the request of applicants who stopped marketing the products.